NEW YORK (
) -- The market ended a volatile week on the upside.
Dow Jones Industrial Average
rose 22.32, or 0.20%, to 11, 203.55 and the
added 3.04, or 0.25%, to 1,199.73. The
edged up 3.72, or 0.15%, to 2,518.12.
Brian Kelly said on
's "Fast Money" TV show said the reversal in the markets the past two days sets up nicely for what he expects will be a bullish week.
Joe Terranova said next week will be a prelude to the week after when some important data comes out, including the unemployment report, China's PMI and ISM report.
For a breakout of some stocks from a recent "Fast Money" TV show, check out Dan Fitzpatrick's "3 Stocks I Saw on TV."
3 Stocks I Saw on TV
var config = new Array(); config<BRACKET>"videoId"</BRACKET> = 680653233001; config<BRACKET>"playerTag"</BRACKET> = "TSCM Embedded Video Player"; config<BRACKET>"autoStart"</BRACKET> = false; config<BRACKET>"preloadBackColor"</BRACKET> = "#FFFFFF"; config<BRACKET>"useOverlayMenu"</BRACKET> = "false"; config<BRACKET>"width"</BRACKET> = 265; config<BRACKET>"height"</BRACKET> = 255; config<BRACKET>"playerId"</BRACKET> = 1243645856; createExperience(config, 8);
Guy Adami was impressed with the market action on
, a stock with a "tremendous story" and a potential takeover target.
Steve Grasso lamented the lack of participation of the financials in this week's rally. Kelly said the financials look "frightening" after
Chairman Ben Bernanke said they were the weak channel in the economy.
Moving to technology and
, which reports earnings next week, Bill Fearnley Jr., an analyst with Janney Capital Markets, said he doesn't expect any big announcements and expressed confidence in the management team.
Stephen Weiss said he was not a buyer of the stock because he didn't know anything about the CEO. "It's a show-me stock," he said.
Terranova said the tell will be whether investors start moving their money from
Looking to retail earnings next week, Adami said the trade he would make would be with credit card issuer
. Kelly liked
, saying it is historically cheap and sets up nicely for a technology-driven holiday season in which the iPad will be the gift. Terranova said he would invest in any company like
that aims at the affluent consumer.
Switching to biotech, Dr. Mark Schoenebaum, an analyst with ISI group, sees
rising 30% over the next six months after the FDA approved its drug to treat lupus. He also liked
, which he said is working on a pill for a rare lung disease that could generate as much as $1 billion in sales and a 10% to 30% pop in the stock.
In the final trades, Kelly liked
, while Adami said to pick up
on a dip. Grasso liked
. And Terranova liked
--Written by David Tong in San Francisco.
To contact the writer of this article, click here:
To follow the writer on Twitter, go to
To submit a news tip, send an email to:
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC
Follow TheStreet.com on
and become a fan on